Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011–2012

BACKGROUND: Generic drug policies are often associated with concerns about the quality and effectiveness of these products. Phase IV clinical trials may be a suitable design to assess the effectiveness and safety of generic drugs. The objective of this study was to describe the effectiveness and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Galindo, Jaime, Amariles, Pedro, Mueses-Marín, Héctor F., Hincapié, Jaime A., González-Avendaño, Sebastián, Galindo-Orrego, Ximena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048459/
https://www.ncbi.nlm.nih.gov/pubmed/27716093
http://dx.doi.org/10.1186/s12879-016-1871-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048459/
https://www.ncbi.nlm.nih.gov/pubmed/27716093
http://dx.doi.org/10.1186/s12879-016-1871-x

Ejemplares similares